Basilea in-licenses targeted cancer therapy

| April 1, 2015 | 0 Comments

BASEL, Switzerland — Basilea Pharmaceutica Ltd. (SIX: BSLN) reports today that it has entered into a license agreement for novel panRAF kinase inhibitors with a consortium of organizations including The …

More here:
Basilea in-licenses targeted cancer therapy

Tags: , , , , , , , , , , ,

Category: Recent News

About the Author ()

Leave a Reply